Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 10836
TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572502(5-Chloro-2-cyanopyridin-3-yl 3-[4-(4-chloro-3,5-di...)
Affinity DataKd:  34nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572510(5-Chloro-2-cyanopyridin-3-yl 3-[4-(5-chloro-6-fluo...)
Affinity DataKd:  350nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572509(5-Ethynylpyridin-3-yl 3-[4-(4-chloro-3,5-difluorop...)
Affinity DataKd:  35nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572508(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  21nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572507(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  16nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572506(5-Bromo-2-cyanopyridin-3-yl 3-[4-(4-chloro-3-fluor...)
Affinity DataKd:  37nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572505(5-Bromo-2-cyanopyridin-3-yl 3-[4-(4-chloro-3,5-dif...)
Affinity DataKd:  23nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572504(2-Cyano-5-methylpyridin-3-yl 3-[4-(4-chloro-3,5-di...)
Affinity DataKd:  50nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572503(5-Chloro-2-cyanopyridin-3-yl 3-[4-(4-chloro-3-fluo...)
Affinity DataKd:  31nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572511(2-Cyano-5-ethynylpyridin-3-yl 3-[4-(4-chloro-3,5-d...)
Affinity DataKd:  28nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572501(5-Chloro-2-cyanopyridin-3-yl 3-deoxy-3-[4-(3,4,5-t...)
Affinity DataKd:  35nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572500(3-Chloro-2-cyanopyridin-5-yl 3-deoxy-3-[4-(3,4,5-t...)
Affinity DataKd:  65nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572499(5-Chloropyridin-3-yl 3-[4-(5-chloro-6-methylpyridi...)
Affinity DataKd:  880nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572498(5-Chloropyridin-3-yl 3-deoxy-3-[4-(6-fluoro-5-meth...)
Affinity DataKd:  39nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572497(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluoro...)
Affinity DataKd:  29nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572496(2-(N-azetidinyl-carbonyl)-5-chlorophenyl 3-deoxy-3...)
Affinity DataKd:  7nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572495(2-(N-azetidinyl-carbonyl)-5-chlorophenyl 3-[4-(4-c...)
Affinity DataKd:  15nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572494(6-Trifluoromethyl-5-methylpyridin-3-yl 3-[4-(4-chl...)
Affinity DataKd:  280nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572512(2-Cyano-5-ethynylpyridin-3-yl 3-deoxy-3-[4-(3,5-di...)
Affinity DataKd:  35nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572513(5-Cyano-6-trifluoromethylpyridin-3-yl 3-[4-(4-chlo...)
Affinity DataKd:  190nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572514(5-Cyanopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  76nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572515(5-Cyanopyridin-3-yl 3-[4-(4-chloro-3,5-difluorophe...)
Affinity DataKd:  80nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572516(5-Bromo-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-(...)
Affinity DataKd:  7nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572517(5-Bromo-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-deox...)
Affinity DataKd:  6nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572518(5-Bromo-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-(...)
Affinity DataKd:  8nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572519(2-(N-azetidinyl-carbonyl)-5-bromophenyl 3-deoxy-3-...)
Affinity DataKd:  16nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572520(2-(N-azetidinyl-carbonyl)-5-bromophenyl 3-deoxy-3-...)
Affinity DataKd:  18nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572521(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  10nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572522(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-deo...)
Affinity DataKd:  21nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572523(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  17nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572524(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  11nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572525(2-(N-azetidinyl-carbonyl)-5-chlorophenyl 3-deoxy-3...)
Affinity DataKd:  12nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572526(3,4-Dichlorophenyl 3-[4-(4-chloro-3,5-difluorophen...)
Affinity DataKd:  250nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572469(5-Chloro-2-cyanopyridin-3-yl 3-deoxy-3-[4-(3-fluor...)
Affinity DataKd:  14nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572477(5-Chloro-6-cyano-2-{N-(2-oxa)-6-azaspiro[3.3]hepta...)
Affinity DataKd:  60nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572476(3,4-Dichlorophenyl 3-[4-(4-chloro-3,5-difluorophen...)
Affinity DataKd:  58nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572475(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  71nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572474(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  20nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572473(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  150nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572472(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  74nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572471(5-Chloro-2- cyanopyridin-3-yl 3- deoxy-2-O-ethyl-...)
Affinity DataKd:  59nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572470(5-Chloro-2-cyanophenyl 3-deoxy-3-[4-(3,5-difluoro-...)
Affinity DataKd:  50nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572478(5-Chloro-6-cyano-2-{N-(2-oxa)-6-azaspiro[3.3]hepta...)
Affinity DataKd:  37nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572468(5-Chloro-2-cyanopyridin-3-yl 3-deoxy-3-[4-(3,5-dif...)
Affinity DataKd:  12nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572467(5-Chloro-2-{N-(2-oxa)-6-azaspiro[3.3]heptanyl}-pyr...)
Affinity DataKd:  49nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572466(5-Chloro-2-{N-(2-oxa)- 6- azaspiro[3.3]heptanyl}...)
Affinity DataKd:  33nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572465(2-(N-piperidinyl-carbonyl)-5-chlorophenyl 3-[4-(4-...)
Affinity DataKd:  120nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572464(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  82nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572463(4-Chloro-N,N-dimethyl-benzamide-2-yl 3-[4-(4-chlor...)
Affinity DataKd:  14nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572462(4-Chloro-N,N- dimethyl-benzamide-2- yl 3-deoxy-3...)
Affinity DataKd:  8nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: